Literature DB >> 33854067

Comprehensive omic characterization of breast cancer in Mexican-Hispanic women.

Sandra L Romero-Cordoba1,2,3, Ivan Salido-Guadarrama4, Rosa Rebollar-Vega5,6,7, Veronica Bautista-Piña8, Carlos Dominguez-Reyes8, Alberto Tenorio-Torres8, Felipe Villegas-Carlos8, Juan C Fernández-López9, Laura Uribe-Figueroa5, Luis Alfaro-Ruiz5, Alfredo Hidalgo-Miranda10.   

Abstract

Breast cancer is a heterogeneous pathology, but the genomic basis of its variability remains poorly understood in populations other than Caucasians. Here, through DNA and RNA portraits we explored the molecular features of breast cancers in a set of Hispanic-Mexican (HM) women and compared them to public multi-ancestry datasets. HM patients present an earlier onset of the disease, particularly in aggressive clinical subtypes, compared to non-Hispanic women. The age-related COSMIC signature 1 was more frequent in HM women than in those from other ancestries. We found the AKT1E17K hotspot mutation in 8% of the HM women and identify the AKT1/PIK3CA axis as a potentially druggable target. Also, HM luminal breast tumors present an enhanced immunogenic phenotype compared to Asiatic and Caucasian tumors. This study is an initial effort to include patients from Hispanic populations in the research of breast cancer etiology and biology to further understand breast cancer disparities.

Entities:  

Year:  2021        PMID: 33854067     DOI: 10.1038/s41467-021-22478-5

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  66 in total

1.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico.

Authors:  Irma Silva-Zolezzi; Alfredo Hidalgo-Miranda; Jesus Estrada-Gil; Juan Carlos Fernandez-Lopez; Laura Uribe-Figueroa; Alejandra Contreras; Eros Balam-Ortiz; Laura del Bosque-Plata; David Velazquez-Fernandez; Cesar Lara; Rodrigo Goya; Enrique Hernandez-Lemus; Carlos Davila; Eduardo Barrientos; Santiago March; Gerardo Jimenez-Sanchez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-11       Impact factor: 11.205

2.  Genomics is failing on diversity.

Authors:  Alice B Popejoy; Stephanie M Fullerton
Journal:  Nature       Date:  2016-10-13       Impact factor: 49.962

3.  Breast cancer--thinking globally.

Authors:  Benjamin O Anderson
Journal:  Science       Date:  2014-03-28       Impact factor: 47.728

Review 4.  Significance of immunohistochemistry in breast cancer.

Authors:  Dana Carmen Zaha
Journal:  World J Clin Oncol       Date:  2014-08-10

5.  Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits.

Authors:  Andrés Moreno-Estrada; Christopher R Gignoux; Juan Carlos Fernández-López; Fouad Zakharia; Martin Sikora; Alejandra V Contreras; Victor Acuña-Alonzo; Karla Sandoval; Celeste Eng; Sandra Romero-Hidalgo; Patricia Ortiz-Tello; Victoria Robles; Eimear E Kenny; Ismael Nuño-Arana; Rodrigo Barquera-Lozano; Gastón Macín-Pérez; Julio Granados-Arriola; Scott Huntsman; Joshua M Galanter; Marc Via; Jean G Ford; Rocío Chapela; William Rodriguez-Cintron; Jose R Rodríguez-Santana; Isabelle Romieu; Juan José Sienra-Monge; Blanca del Rio Navarro; Stephanie J London; Andrés Ruiz-Linares; Rodrigo Garcia-Herrera; Karol Estrada; Alfredo Hidalgo-Miranda; Gerardo Jimenez-Sanchez; Alessandra Carnevale; Xavier Soberón; Samuel Canizales-Quinteros; Héctor Rangel-Villalobos; Irma Silva-Zolezzi; Esteban Gonzalez Burchard; Carlos D Bustamante
Journal:  Science       Date:  2014-06-12       Impact factor: 47.728

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  [Breast cancer in Mexico: an urgent priority].

Authors:  Felicia Marie Knaul; Gustavo Nigenda; Rafael Lozano; Héctor Arreola-Ornelas; Ana Langer; Julio Frenk
Journal:  Salud Publica Mex       Date:  2009

Review 8.  Breast cancer in Mexico: a growing challenge to health and the health system.

Authors:  Yanin Chávarri-Guerra; Cynthia Villarreal-Garza; Pedro E R Liedke; Felicia Knaul; Alejandro Mohar; Dianne M Finkelstein; Paul E Goss
Journal:  Lancet Oncol       Date:  2012-08       Impact factor: 41.316

9.  Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy.

Authors:  Cynthia Villarreal-Garza; Juan Enrique Bargallo-Rocha; Enrique Soto-Perez-de-Celis; Federico Lasa-Gonsebatt; Claudia Arce-Salinas; Fernando Lara-Medina; Nancy Reynoso-Noverón; Juan Matus-Santos; Paula Cabrera; Alberto Alvarado-Miranda; Alejandro Mohar
Journal:  Breast Cancer Res Treat       Date:  2016-05-17       Impact factor: 4.872

10.  Pan-cancer patterns of somatic copy number alteration.

Authors:  Travis I Zack; Stephen E Schumacher; Scott L Carter; Andre D Cherniack; Gordon Saksena; Barbara Tabak; Michael S Lawrence; Cheng-Zhong Zhsng; Jeremiah Wala; Craig H Mermel; Carrie Sougnez; Stacey B Gabriel; Bryan Hernandez; Hui Shen; Peter W Laird; Gad Getz; Matthew Meyerson; Rameen Beroukhim
Journal:  Nat Genet       Date:  2013-10       Impact factor: 38.330

View more
  3 in total

1.  Pan-cancer analysis reveals homologous recombination deficiency score as a predictive marker for immunotherapy responders.

Authors:  Can Yang; Zijing Zhang; Xuemei Tang; Xinju Zhang; Yuming Chen; Tingting Hu; Huating Zhang; Ming Guan; Xiuming Zhang; Zhiyuan Wu
Journal:  Hum Cell       Date:  2021-10-10       Impact factor: 4.174

2.  Systemic sclerosis manifestations and clinical outcomes in Hispanics/Latinos of the American Southwest.

Authors:  Sharon E Nunez; Angie Ariza-Hutchinson; Roderick A Fields; Jaime A Vondenberg; Rosemina A Patel; N Suzanne Emil; Maheswari Muruganandam; James I Gibb; Janet L Poole; Wilmer L Sibbitt
Journal:  J Scleroderma Relat Disord       Date:  2022-04-10

3.  Twist1 Influences the Expression of Leading Members of the IL-17 Signaling Pathway in HER2-Positive Breast Cancer Cells.

Authors:  Bruno R B Pires; Renata Binato; Gerson M Ferreira; Stephany Corrêa; Bárbara Du Rocher; Daniel Bulzico; Susanne Crocamo; Everton Cruz Dos Santos; Luize G Lima; Eliana Abdelhay
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.